Company Sets New Quarterly Record
for Number of Individual E-Commerce Order Transactions
New York, NY -- March 25, 2022 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB:
TAUG) (“Tauriga” or the “Company”), a New York based
diversified Life Sciences and Pharmaceutical Development Company,
today announced that it has received its
10,000thE-Commerce order. The Company has
also set a new Quarterly record for “number of individual
E-Commerce transactions.” Driving the strong performance
in the Company’s E-Commerce business (its highest margin segment),
are the following factors: increasing number of orders from repeat
customers, expansion of product offerings, influencer-based
marketing initiatives, and higher conversion rates (with respect to
visitors to E-Commerce website).
E-Commerce Website: www.taurigum.com
In other news, the Company is pleased about the recently
announced progress, pertaining to potential Federal Legalization
Legislation. On March 24, 2022, the U.S. House of
Representatives officially scheduled a Floor Vote for “Federal
Marijuana Legalization Bill.” This Vote is expected to
take place next week (March 28th– April 1st,
2022).
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and initiatives. The company
manufactures and distributes several proprietary retail products
and product lines, mainly focused on the Cannabidiol ("CBD") and
Cannabigerol ("CBG") Edibles market segment. The main product line,
branded as Tauri-Gum(TM), consists of a proprietary supplement
chewing gum that is Kosher certified, Halal certified, and Vegan
Formulated (CBD Infused Tauri-Gum(TM) Flavors: Mint, Blood Orange,
Pomegranate), (CBG Infused Tauri-Gum(TM) Flavors: Peach-Lemon,
Black Currant), (DELTA 8 THC Infused Tauri-Gum(TM) Flavor:
Evergreen Mint), (Vitamin C + Zinc Infused Tauri-Gum(TM) Flavor:
Pear Bellini), (Caffeine Infused Tauri-Gum(TM) Flavor: Cherry Lime
Rickey), & (Vitamin D3 Infused Tauri-Gum(TM) Flavor: Golden
Raspberry). The Company's commercialization strategy consists of a
broad array of retail customers, distributors, and a fast-growing
E-Commerce business segment (E-Commerce website: www.taurigum.com).
Please visit our corporate website, for additional information, as
well as inquiries, at http://www.tauriga.com
Complementary to the Company's retail business, is its ongoing
Pharmaceutical Development initiative. This relates to the
development of a proposed Pharmaceutical grade version of
Tauri-Gum(TM), for nausea regulation (specifically designed for the
following indication: Patients Subjected to Ongoing Chemotherapy
Treatment). On March 22, 2021, the Company announced that it had
Converted its U.S. Provisional Patent Application (filed on March
17, 2020) into a U.S. Non-Provisional Patent Application. The
Patent, filed with the U.S.P.T.O. is Titled "MEDICATED CBD
COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT".
On December 18, 2020 the Company disclosed that it had entered into
a Master Services Agreement with CSTI to lead the Company's
clinical development efforts.
The Company is headquartered in Wappingers Falls, New York. In
addition, the Company operates two full time E-Commerce fulfillment
centers: one located in Montgomery, Texas and the other in
Brooklyn, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due to known and
unknown risks and uncertainties, such as are not guarantees of
general economic and business conditions, the ability to
successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other periodic filings made from time to time with the
Securities and Exchange Commission. Such forward-looking statements
are made only as of the date of this release, and Tauriga assumes
no obligation to update forward-looking statements to reflect
subsequent events or circumstances. You should not place undue
reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com